TRAW
Traws Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.55
+1.49%Margins
Gross margin
99.9%
EBITDA margin
-858.3%
EBIT margin
-863.8%
Net margin
-858.1%
FCF margin
-550.3%
450.8%
Return on equity
-293.5%
Return on assets
453.8%
Return on invested capital
0.30x
Asset turnover
-$15.4M
Cash from operations
$0.20
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026